Skip to main content

Find Clinical Trials

Home
Conditions
Lupus Erythematosus, Systemic

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies

Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

Efficacy of Vitamin C Supplementation on Malondialdehid Levels and Disease Activity in SLE Patients

NCT07083622

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Mohammad Hoesin General Hospital Palembang, South Sumatera, Indonesia

View Trial Details

Completed

Efficacy of Vitamin C Supplementation on Serum TNF-α Levels and Disease Activity in SLE Patients

NCT07071233

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Mohammad Hoesin General Hospital Palembang, South Sumatera, Indonesia

View Trial Details

Completed

Efficacy of Vitamin C Supplementation on Serum IL-6 Levels and Disease Activity in Systemic Lupus Erythematosus Patients

NCT07071220

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Mohammad Hoesin General Hospital Palembang, South Sumatera, Indonesia

View Trial Details

Completed

Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients

NCT07048470

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Mohammad Hoesin General Hospital Palembang, South Sumatera, Indonesia

View Trial Details

Completed

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

NCT04870333

Conditions: Autoimmune Diseases, COVID-19, Cardiovascular Diseases, +27 more
Locations: Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom

NHS Lanarkshire - University Hospital Monklands Airdrie, United Kingdom

University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom

Betsi Cadwaladr University Health Board Bodelwyddan, United Kingdom

View all 45 locations

View Trial Details

Completed

Belimumab (BENLYSTA®) Pregnancy Registry

NCT01532310

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: GSK Investigational Site Wilmington, North Carolina, United States

GSK Investigational Site Wilmington, North Carolina, United States

GSK Investigational Site Innsbruck, Austria

GSK Investigational Site Liège, Belgium

View all 15 locations

View Trial Details

Completed

The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE

NCT07012239

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Genetic Polymorphism, +3 more
Locations: Mohammad Abul Kalam Azad Dhaka, Bangladesh

View Trial Details

Completed

Occupational and Environmental Causes of Autoimmune Diseases

NCT07000903

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +11 more
Locations: Cliniques universitaires Saint-Luc Brussels, Brussels Capital, Belgium

View Trial Details

Completed

Efficacy and Safety of Belimumab in SLE Patients

NCT04515719

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Shuang Ye, MD Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

NCT06046534

Conditions: Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations: Research Site Brest, France

Research Site Caen, France

Research Site Dijon, France

Research Site Lille, France

View all 15 locations

View Trial Details